财务摘要(报告期)(Taro Pharmaceutical Industries Ltd)
2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|---|
每股指标: | |||||||
每股收益EPS基本(元) | 1.03 | 0.49 | 0.27 | 0.68 | 0.49 | 0.30 | 0.37 |
每股净资产(元) | 47.34 | 46.50 | 46.26 | 46.05 | - | 45.40 | 45.60 |
每股经营现金净流量(元) | 2.29 | 1.47 | 0.21 | 0.84 | -0.66 | -1.00 | -1.54 |
每股现金流量净额(元) | 6.06 | 3.05 | -0.81 | -2.57 | -4.23 | -2.02 | -0.67 |
每股营业收入(元) | 12.35 | 8.17 | 4.23 | 15.24 | 11.34 | 7.64 | 4.17 |
盈利能力: | |||||||
销售毛利率(%) | 46.87 | 44.83 | 40.33 | 46.83 | 45.18 | 44.77 | 52.09 |
销售净利率(%) | 8.36 | 6.05 | 6.31 | 4.44 | 4.35 | 3.92 | 8.99 |
净资产收益率平均(%) | 2.21 | 1.07 | 0.58 | 1.48 | - | 0.66 | 0.82 |
总资产净利率(%) | 1.80 | 0.87 | 0.47 | 1.18 | - | 0.53 | 0.66 |
投入资本回报率ROIC(%) | 2.06 | 0.97 | 0.50 | 1.30 | - | 0.58 | 0.74 |
收益质量: | |||||||
营业利润/利润总额(%) | 22.50 | -13.78 | -145.63 | 46.36 | 41.55 | 64.28 | 87.06 |
税项/利润总额(%) | 31.27 | 19.55 | -84.43 | 33.41 | 8.77 | -1.13 | 12.30 |
经营活动产生的现金流量净额/营业收入(%) | 18.57 | 18.01 | 4.89 | 5.54 | -5.84 | -13.12 | -37.04 |
资本结构: | |||||||
资产负债率(%) | 17.76 | 17.55 | 18.57 | 18.95 | - | 19.03 | 19.16 |
权益乘数 | 1.22 | 1.21 | 1.23 | 1.23 | 1.00 | 1.24 | 1.24 |
产权比率 | 0.22 | 0.21 | 0.23 | 0.23 | - | 0.24 | 0.24 |
流动资产/总资产(%) | 62.29 | 63.34 | 60.62 | 62.58 | - | 64.38 | 63.60 |
非流动资产/总资产(%) | 37.71 | 36.66 | 39.38 | 37.42 | - | 35.62 | 36.40 |
流动负债/负债合计(%) | 97.39 | 97.20 | 97.10 | 95.28 | - | 93.48 | 92.17 |
非流动负债/负债合计(%) | 2.61 | 2.80 | 2.90 | 4.72 | - | 6.52 | 7.83 |
归属母公司股东的权益/投入资本(%) | 99.91 | 94.44 | 86.46 | 87.37 | - | 88.31 | 90.47 |
偿债能力: | |||||||
流动比率 | 3.60 | 3.71 | 3.36 | 3.47 | - | 3.62 | 3.60 |
速动比率 | 3.03 | 3.14 | 2.83 | 2.88 | - | 3.04 | 3.02 |
货币资金/流动负债(%) | 102.23 | 74.42 | 32.25 | 40.07 | - | 46.74 | 60.30 |
营业利润/流动负债(%) | 3.40 | -0.88 | -2.06 | 4.59 | - | 1.91 | 3.73 |
经营活动产生的现金流量净额/流动负债(%) | 23.05 | 15.30 | 2.02 | 8.24 | - | -10.05 | -15.50 |
归属母公司股东的权益/负债合计(%) | 463.20 | 469.88 | 438.45 | 427.74 | - | 425.51 | 421.81 |
经营活动产生的现金流量净额/负债合计(%) | 22.45 | 14.87 | 1.96 | 7.85 | - | -9.39 | -14.28 |
营业利润/负债合计(%) | 3.31 | -0.86 | -2.00 | 4.38 | - | 1.79 | 3.44 |
成长能力: | |||||||
总资产同比增长率(%) | - | 0.58 | 0.71 | -1.88 | - | -9.06 | -12.15 |
每股净资产同比增长率(%) | - | 2.42 | 1.45 | 1.13 | -100.00 | 2.91 | 4.30 |
总负债同比增长率(%) | - | -7.25 | -2.40 | -12.96 | - | -37.74 | -46.21 |
基本每股收益同比增长率(%) | 110.20 | 63.33 | -27.03 | -56.13 | -40.24 | 150.00 | 174.00 |
归属母公司股东的权益同比增长率(%) | - | 2.42 | 1.45 | 1.13 | - | 1.98 | 3.36 |
营业利润同比增长率(%) | 50.49 | -144.44 | -156.68 | -72.09 | -79.99 | 37.32 | 172.68 |
营业收入同比增长率(%) | 8.88 | 6.94 | 1.42 | 2.07 | 1.98 | 2.89 | 6.49 |
股东权益合计同比增长率(%) | - | 2.42 | 1.45 | 1.13 | - | 1.98 | 3.36 |
营运能力: | |||||||
存货周转率次(次) | 1.12 | 0.78 | 0.44 | 1.39 | - | 0.74 | 0.35 |
流动资产周转率次(次) | 0.35 | 0.23 | 0.12 | 0.43 | - | 0.21 | 0.12 |
固定资产周转率次(次) | 2.27 | 1.62 | 0.84 | 2.94 | - | 1.47 | 0.79 |
总资产周转率次(次) | 0.22 | 0.14 | 0.07 | 0.27 | - | 0.13 | 0.07 |
衍生指标: | |||||||
现金及现金等价物净增加额TTM(元) | 93,820,000.00 | -101,636,000.00 | -96,639,000.00 | -226,130,000.00 | -348,477,000.00 | -389,087,000.00 | -354,043,000.00 |
利润总额TTM(元) | 50,169,000.00 | 27,600,000.00 | 38,213,000.00 | 45,329,000.00 | 75,657,000.00 | 109,990,000.00 | 77,858,000.00 |
毛利TTM(元) | 277,441,000.00 | 250,801,000.00 | 268,323,000.00 | 269,960,000.00 | 281,947,000.00 | 297,030,000.00 | 293,122,000.00 |
投入资本(元) | 1,780,770,000.00 | 1,850,462,000.00 | 2,010,884,000.00 | 1,981,018,000.00 | - | 1,932,088,000.00 | 1,894,191,000.00 |
经营活动产生的现金流量净额TTM(元) | 124,710,000.00 | 97,555,000.00 | 31,750,000.00 | 16,358,000.00 | -188,342,000.00 | -260,719,000.00 | -158,698,000.00 |
总营业收入TTM(元) | 592,885,000.00 | 575,181,000.00 | 572,952,000.00 | 569,629,000.00 | 569,411,000.00 | 570,899,000.00 | 561,347,000.00 |
归属母公司净利润TTM(元) | 32,760,000.00 | 21,399,000.00 | 25,445,000.00 | 45,936,000.00 | 64,983,000.00 | 91,112,000.00 | 58,266,000.00 |
所得税TTM(元) | 17,409,000.00 | 6,201,000.00 | 12,768,000.00 | -607,000.00 | 10,674,000.00 | 18,878,000.00 | 19,592,000.00 |